All the Latest News


Archive: March 2016


Iceni Pharmaceuticals parent company BigDNA Ltd announces completion of internal funding round

Edinburgh, UK. 1 March 2016. BigDNA Ltd, parent organisation of oncology drug development company Iceni Pharmaceuticals announced today that it has completed a £0.5M investment round from internal shareholders, including London-based Imprimatur Capital and the Scottish Investment Bank.
Read more